UM Saint Joseph Medical Center

Summary

UM Saint Joseph Medical Center is a medical facility located in Towson, Maryland. This center is recognized for care of Breast Cancer, Breast cancer, Coronary Artery Disease, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. UM Saint Joseph Medical Center is involved with conducting 55 clinical trials across 100 conditions. There are 5 research doctors associated with this hospital, such as Kimberly W. Schlesinger, Richard M. Schraeder, Jason R. Citron, and Selvi Lingam.

Top PIs

Clinical Trials running at UM Saint Joseph Medical Center

Breast Cancer

Pancreatic Cancer

Colorectal Cancer

Cancer

Lung Cancer

Bladder Cancer

Prostate Cancer

Lymphoma

Melanoma

Ovarian Cancer

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.

Recruiting

2 awards

Phase 3

19 criteria

Mindfulness Approaches

for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

Recruiting

2 awards

Phase 3

5 criteria

ctDNA MRD Test

for Breast Cancer

The EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and blood specimens for circulating tumor DNA (ctDNA) analysis. Participants will be followed for up to 5.5 years.

Recruiting

1 award

N/A

10 criteria